Data / Form D filings / XORTX Therapeutics Inc.
XORTX Therapeutics Inc.: Form D filings
XORTX Therapeutics Inc., a company in Calgary, Alberta, Canada, filed 2 Form D notices with the SEC between 2018 and 2024. The latest, on October 31, 2024, reports an offering of $1.8 million with nothing sold yet to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3710 - 33rd Street NW, Calgary, Alberta, Canada, T2L 2
- Phone
- (403) 455-7727
- Industry
- Other
- Entity type
- Corporation
- Incorporated in
- British Columbia, Canada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1729214
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 31, 2024 | New notice | $1,767,566 | $0 | $1,767,566 | 1 | Oct 18, 2024 | sec.gov |
| Jan 25, 2018 | New notice | $505,283 | $505,283 | 1 | Jan 10, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Allen Davidoff | Executive Officer, Director | |
| Paul J. Van Damme | Director | |
| Abigail J. Jenkins | Director | |
| Stephen Haworth | Executive Officer | |
| Stacy Evans | Executive Officer | |
| James Fairbairn | Executive Officer | |
| William Farley | Director | |
| Anthony J. Giovinazzo | Director | |
| Raymond J. Pratt | Director | |
| Patrick J. Treanor | Director |
Every Form D from the week of Oct 28, 2024 · All recent Other filings
Read from SEC EDGAR. Amount sold is what XORTX Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.